Overview

Drug Discovery Informatics Market is projected to value over USD 4.02 billion by 2027 end with a CAGR of over 9% during the forecast period 2020 to 2027.

The escalating expenditure on research and development, increased usage of informatics for discovering drugs and increased funding for research on rare and chronic diseases are some of the crucial factors responsible for the drug discovery informatics market growth. Conversely, a lack of skilled healthcare personnel and the steep cost of setting up the informatics software shall impede the market growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Discovery Informatics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Drug Discovery Informatics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Drug Discovery Informatics Market:
• Jubilant Life Sciences
• Charles River Laboratories International
• IBM
• Clarivate Analytics
• Accenture
• Perkinelmer
• Dassault Systèmes
• Eurofins Scientific
• Evotec AG
• Cognizant
• Infosys Limited
• Thermo Fisher Scientific
• Albany Molecular Research
• Schrodinger
• Selvita
• Certara
• GVK Biosciences
• Openeye Scientific Software
• IO Informatics
• CDD
(Note: The list of the major players will be updated with the latest market scenario and trends) 

Market Segmentation:

By Function
•    Sequencing and Target Data Analysis
•    Docking
•    Molecular Modeling
•    Library & Database Preparation
•    Other Functions      

By Application
•    Drug Discovery
•    Drug Development

By Solution
•    Software
•    Services

By End User
•    Pharmaceutical Companies
•    Biotechnology Companies
•    Contract Research Organizations 
•    Other End Users    

By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into function, application, solution, end user and region. The function segment is fragmented into sequencing and target data analysis, docking, molecular modelling, library and database preparation and other functions. The sequencing and target data analysis segment is predicted to hold the largest drug discovery informatics market share owing to a wide range of applications for sequencing analysis for new drugs and it is easy for handling information from different domains. The application segment is divided into drug discovery and drug development. The solutions segment is bifurcated into software and services. The end user segment is segregated into pharmaceutical companies, biotech companies, contract research organizations and other end users.

Regional Analysis:

The North America region is expected to dominate the market owing to advancements in drug discovery technology, increased research and development activities related to drug discovery and a strong presence of key market players in the region. 

Competitive Landscape:                            

•    Tier 1 players- established companies in the market with a major market share
•    Tier 2 players
•    Emerging players which are growing rapidly
•    New Entrants

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global drug discovery informatics market by function, by application, by solution, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions      

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
          1.1 Objectives of the Study 
          1.2 Market Definition 
          1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
         1.4 Currency
         1.5 Limitations 
         1.6 Stakeholders     
2. Research Methodology 
         2.1 Research Data 
               2.1.1 Secondary Data
                        2.1.1.1 Key Data from Secondary Sources
               2.1.2 Primary Data
                        2.1.2.1 Key Data from Primary Sources
         2.2 Market Size Estimation 
         2.3 Market Breakdown and Data Triangulation 
         2.4 Assumptions for the Study  
3. Executive Summary
         3.1 Market Outlook
         3.2 Segment Outlook
         3.3 Competitive Insights
4. Market Variables, Trends & Scope
         4.1 Market Lineage Outlook
         4.2 Penetration and Growth Prospect Mapping
         4.3 Industry Value Chain Analysis
         4.4 Cost Analysis Breakdown
         4.5 Technology Overview
         4.6 Regulatory Framework on Country Level
                 4.6.1 Reimbursement Framework    
                 4.6.2 Standards and Compliances
5. Market Overview
         5.1 Market Dynamics
               5.1.1 Market Driver Analysis         
               5.1.2 Market Restraint Analysis         
               5.1.3 Industry Challenges                   
6. Market Analysis tools                       
         6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
         6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. Drug Discovery Informatics Market, By Function Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         7.1 Sequencing and Target Data Analysis
         7.2 Docking
         7.3 Molecular Modeling
         7.4 Library & Database Preparation
         7.5 Other Functions                    
8. Drug Discovery Informatics Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         8.1 Drug Discovery
         8.2 Drug Development
9. Drug Discovery Informatics Market, By Solution Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         9.1 Software
         9.2 Services
10. Drug Discovery Informatics Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         10.1 Pharmaceutical Companies
         10.2 Biotechnology Companies
         10.3 Contract Research Organizations 
         10.4 Other End Users    
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                11.2.1. U.S.
                11.2.2. Canada
                11.2.3. Mexico 
                11.2.4. Rest of North America
         11.3 Market Size (USD Mn) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         12.1. Introduction
         12.2. Regional Market Trends
         12.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.3.1. Brazil
                12.3.2. Venezuela
                12.3.3. Argentina
                12.3.4. Rest of Latin America
         12.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         13.1. Introduction
         13.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                13.2.1. Germany
                13.2.2. U.K
                13.2.3. France
                13.2.4. Italy
                13.2.5 Switzerland
                13.2.6. Spain
                13.2.7. Russia
                13.2.8. Poland
                13.2.9. Rest of Western Europe
         13.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         14.1 Introduction
         14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 14.2.1 Japan
                 14.2.2 China
                 14.2.3 Singapore
                 14.2.4 Korea         
                 14.2.5 India
                 14.2.6 Australia and New Zealand
                 14.2.7 ASEAN
                 14.2.8 Rest of Asia Pacific
          14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
     15.1 Introduction
     15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
            15.2.1 UAE
            15.2.2 South Africa
            15.2.3 Egypt
            15.2.4 Saudi Arabia
            15.2.5 Rest of MEA
     15.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    16.1. Jubilant Life Sciences
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. Charles River Laboratories International
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. IBM
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. Clarivate Analytics
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5. Accenture
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6. Perkinelmer
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview      
    16.7. Dassault Systèmes
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
    16.8. Eurofins Scientific
          16.8.1. Company Overview
          16.8.2. Product Portfolio
          16.8.3. SWOT Analysis
          16.8.4. Financial Overview
          16.8.5. Strategic Overview 
    16.9. Evotec AG
          16.9.1. Company Overview
          16.9.2. Product Portfolio
          16.9.3. SWOT Analysis
          16.9.4. Financial Overview
          16.9.5. Strategic Overview 
    16.10.Cognizant
          16.10.1. Company Overview
          16.10.2. Product Portfolio
          16.10.3. SWOT Analysis
          16.10.4. Financial Overview
          16.10.5. Strategic Overview
    16.11.Infosys Limited
          16.11.1. Company Overview
          16.11.2. Product Portfolio
          16.11.3. SWOT Analysis
          16.11.4. Financial Overview
          16.11.5. Strategic Overview          
    16.12.Thermo Fisher Scientific
          16.12.1. Company Overview
          16.12.2. Product Portfolio
          16.12.3. SWOT Analysis
          16.12.4. Financial Overview
          16.12.5. Strategic Overview      
    16.13.Albany Molecular Research
          16.13.1. Company Overview
          16.13.2. Product Portfolio
          16.13.3. SWOT Analysis
          16.13.4. Financial Overview
          16.13.5. Strategic Overview
    16.14.Schrodinger
          16.14.1. Company Overview
          16.14.2. Product Portfolio
          16.14.3. SWOT Analysis
          16.14.4. Financial Overview
          16.14.5. Strategic Overview 
    16.15.Selvita
          16.15.1. Company Overview
          16.15.2. Product Portfolio
          16.15.3. SWOT Analysis
          16.15.4. Financial Overview
          16.15.5. Strategic Overview 
    16.16.Certara
          16.16.1. Company Overview
          16.16.2. Product Portfolio
          16.16.3. SWOT Analysis
          16.16.4. Financial Overview
          16.16.5. Strategic Overview
    16.16.GVK Biosciences
          16.16.1. Company Overview
          16.16.2. Product Portfolio
          16.16.3. SWOT Analysis
          16.16.4. Financial Overview
          16.16.5. Strategic Overview
    16.18.Openeye Scientific Software
          16.18.1. Company Overview
          16.18.2. Product Portfolio
          16.18.3. SWOT Analysis
          16.18.4. Financial Overview
          16.18.5. Strategic Overview
    16.19.IO Informatics
          16.19.1. Company Overview
          16.19.2. Product Portfolio
          16.19.3. SWOT Analysis
          16.19.4. Financial Overview
          16.19.5. Strategic Overview
    16.20.CDD
          16.20.1. Company Overview
          16.20.2. Product Portfolio
          16.20.3. SWOT Analysis
          16.20.4. Financial Overview
          16.20.5. Strategic Overview
17. Impact of COVID-19
      17.1. Positive influence on the healthcare industry
      17.2. The financial disruption of the manufacturing sector
      17.3. Impact of COVID-19 on emerging companies
      17.4. Significant mandates in the healthcare regulations initiated by administrations
      17.5. The overall economic slowdown of the developing and developed nations
18. Competitive Intelligence and Competitive Matrix
      18.1 Competitive Intelligence
      18.2 Competitive Matrix
19. Major Deals and Strategic Alliances Analysis
      19.1 Joint ventures
      19.2 Mergers and acquisitions              
      19.3 Licensing and partnerships
      19.4 Technology Collaborations
      19.5 Strategic Divestments
      19.6 Market Entry Strategies                        
20. Relevant Case Studies and Latest News Updates
21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics 

Tables

Figures